Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$4.19 - $9.56 $229,436 - $523,486
-54,758 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$4.52 - $7.8 $1.79 Million - $3.09 Million
-396,619 Reduced 87.87%
54,758 $290,000
Q4 2020

Feb 16, 2021

SELL
$4.37 - $9.46 $10.5 Million - $22.8 Million
-2,407,038 Reduced 84.21%
451,377 $3.18 Million
Q3 2020

Nov 16, 2020

BUY
$8.56 - $26.93 $6.33 Million - $19.9 Million
739,415 Added 34.89%
2,858,415 $25.9 Million
Q2 2020

Aug 14, 2020

SELL
$21.21 - $31.55 $161,196 - $239,780
-7,600 Reduced 0.36%
2,119,000 $58.2 Million
Q1 2020

May 15, 2020

SELL
$18.43 - $38.04 $46,075 - $95,100
-2,500 Reduced 0.12%
2,126,600 $46.8 Million
Q4 2019

Feb 14, 2020

BUY
$29.6 - $43.71 $1.52 Million - $2.25 Million
51,400 Added 2.47%
2,129,100 $80.4 Million
Q3 2019

Nov 14, 2019

BUY
$29.87 - $42.22 $3.96 Million - $5.59 Million
132,500 Added 6.81%
2,077,700 $64.1 Million
Q2 2019

Aug 14, 2019

BUY
$31.16 - $39.46 $45.3 Million - $57.4 Million
1,454,900 Added 296.74%
1,945,200 $76.8 Million
Q1 2019

May 15, 2019

SELL
$19.96 - $38.62 $45,908 - $88,826
-2,300 Reduced 0.47%
490,300 $18.9 Million
Q4 2018

Feb 14, 2019

SELL
$23.57 - $32.33 $56,568 - $77,592
-2,400 Reduced 0.48%
492,600 $11.6 Million
Q3 2018

Nov 14, 2018

SELL
$22.5 - $39.35 $112,500 - $196,750
-5,000 Reduced 1.0%
495,000 $15.1 Million
Q2 2018

Aug 14, 2018

BUY
$26.0 - $29.9 $13 Million - $15 Million
500,000 New
500,000 $15 Million

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.